GlassScriptPhysician profile
Charles Yu Hu
NPI 1023578135
$4,619.23
in general payments reported to CMS, 2019-2025
18 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,351 · 2023: $381 · 2024: $273 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,870.58 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $308.79 | 2022-2023 | |
| Supreme Orthopedic Systems, LLC | $287.27 | 2022-2023 | |
| Mimedx Group, INC. | $236.65 | 2025 | |
| Stryker Corporation | $213.79 | 2025 | Prostep Mica, Ortholoc 3di, Swanson |
| Globus Medical, INC. | $88.18 | 2022 | |
| Cashflow Solutions, LLC | $86.22 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Surgenex LLC | $82.36 | 2025 | Ardeograft, Surgraft, Surmatrix |
| Ossio INC | $82.18 | 2023 | |
| Averitas Pharma INC. | $81.16 | 2024 | Qutenza |
| Kerecis Limited | $50.54 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tactile Systems Technology INC | $47.86 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Orthofix Medical, INC. | $38.47 | 2025 | Physio-Stim |
| Smith+Nephew, INC. | $37.65 | 2022-2023 | Pico 7, Renasys Go V2 Home |
| Convatec INC. | $33.16 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $32.89 | 2024 | Senza |
| Organogenesis INC. | $22.77 | 2024 | Affinity |
| Paratek Pharmaceuticals, INC. | $18.71 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.